This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mirum Pharmaceuticals announced inducement awards granted to 37 new employees, comprising stock options, restricted stock units (RSUs), and performance stock units (PSUs). These awards, approved by the Compensation Committee, are designed to align with Nasdaq Listing Rule 5635©(4) and vest over several years based on continued service and, for PSUs, on achieving specific net product sales targets in 2027 and 2028. This move aims to incentivize and retain key talent within the company.